Craig Thompson Named President of Memorial Sloan-Kettering On August 10, 2010, nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center effective November 2, 2010.
Memorial Sloan-Kettering Opens Outpatient Rehabilitation Center Memorial Sloan-Kettering greatly expanded its capacity to help patients with cancer regain physical function and a sense of well-being with the opening recently of its state-of-the-art Outpatient Rehabilitation Center.
An Interview With Alexander Rudensky A member of the Sloan-Kettering Institute’s Immunology Program and a Howard Hughes Medical Institute investigator, Alexander Rudensky is fascinated by how a specific type of white blood cells called regulatory T cells regulates our immune system.
Memorial Sloan-Kettering Enters Agreement to Develop New Cancer Drug As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan-Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.
Sifting Through the Prostate Cancer Genome A team of Memorial Sloan-Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.